Tuberculosis is the world's leading infectious cause of death, killing more than one million people each year. When the antibiotic bedaquiline was introduced in 2012, it was the first new ...

Tuberculosis is one of the top ten causes of death worldwide, infecting about one-quarter of the world's population. Although it is treatable, the rise of multidrug-resistant tuberculosis poses a ...

Scientists have uncovered a promising new pathway in the development of tuberculosis drugs, describing what they call a newly-discovered “keyhole” that can be targeted to starve tuberculosis ...

Cryo-EM structure of the MmpL5-MmpS5-AcpM complex from Mycobacterium tuberculosis. Credit: Nature Communications (2025). DOI: 10.1038/s41467-025-60365-5 ...

The first low-resolution structure, aided by docking with AlphaFold2, the artificial intelligence protein structure prediction system, showed the domain that spans the inner membrane of M.

This bacterial structure explains why TB can withstand harsh environmental conditions and resist many standard antibiotics. ... Tuberculosis sits at the intersection of medical science, ...

Tuberculosis (TB) bacteria infect a third of the world's population and the disease kills 1.8 million people annually. ... Structure of tuberculosis drug target determined ...

Ocular or eye tuberculosis is a rare eye infection that involves the same bacteria as TB in the lungs. Treatment can take several months, but it is usually effective.

Every year, 10 million people contract tuberculosis (TB), a disease caused by the bacterium Mycobacterium tuberculosis (Mtb), and approximately 1.5 million patients succumb to the disease. Treatment ...